How to Invest in Inovio Pharmaceuticals stock
IOVO Pharmaceuticals, Inc. has reported its fourth quarter earnings, and the stock is up $0.01 per share on the day.
That means the stock now trades at $18.19.
IOVO also posted a year-to-date earnings growth rate of 5.2%, which is still good for the fourth quarter of the year.
The company reported revenue of $6.2 billion, up 10% from the same quarter a year ago.
For perspective, the S&P 500 is up more than 9% this year.
IOVOS shares are up more by more than 50% this quarter, thanks to the growth in sales of its generic drug in the US.
But, this is still a pretty decent amount of growth for a company that was once one of the worst performers in the market for pharmaceuticals in the last few years.
Last year, IOVOs growth was about 20%, which isn’t great for a drug that is supposed to be a niche player.
But, Iovos is a company known for its innovative new therapies and has recently launched several new ones.
So, I think the stock price will continue to climb this quarter.
I have an investment strategy in the stock and I am bullish on it.
I’m bullish on IOVON stock.
I want to buy it.